Lorenzen S, Schwarz A, Pauligk C, Goekkurt E, et al. Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/I BMC Cancer 2023;23:561.
PMID: 37337155